Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Sympathetic Neurons Promote Small Cell Lung Cancer through the β2-Adrenergic Receptor
Tala Fnu1,2, Peiguo Shi3,4, Wanwei Zhang5
1Department of Medicine, Columbia Center for Human Development, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York.
Significance:
SCLC is highly aggressive, with limited effective treatment options. We show that ablating sympathetic nerves or inhibiting the ADRB2 receptor slows SCLC progression and prolongs survival in mice. Additionally, ADRB2 inhibition reduces the growth of human SCLC organoids and xenografts by disrupting PKA signaling, identifying a new therapeutic target.
Insights
Targeting sympathetic nerves or the ADRB2 receptor slows small cell lung cancer (SCLC) progression. Inhibiting ADRB2 disrupts PKA signaling, offering a new therapeutic strategy for aggressive SCLC.
Area of Science:
- Oncology
- Neuroscience
- Pharmacology
Background:
- Small cell lung cancer (SCLC) is an aggressive malignancy with limited therapeutic options.
- The role of the sympathetic nervous system in SCLC progression is not well understood.
Purpose of the Study:
- To investigate the role of sympathetic nerve activity and ADRB2 signaling in SCLC.
- To identify novel therapeutic targets for SCLC treatment.
Main Methods:
- Ablation of sympathetic nerves in a mouse model of SCLC.
- Pharmacological inhibition of the ADRB2 receptor in mice, human SCLC organoids, and xenografts.
- Analysis of SCLC progression, survival, and PKA signaling pathways.
Main Results:
- Ablating sympathetic nerves or inhibiting ADRB2 significantly slowed SCLC progression and improved survival in mice.
- ADRB2 inhibition reduced the growth of human SCLC organoids and xenografts.
- ADRB2 inhibition was found to disrupt PKA signaling in SCLC cells.
Conclusions:
- Sympathetic nerve activity and ADRB2 signaling represent a potential therapeutic vulnerability in SCLC.
- Targeting ADRB2 offers a promising new strategy for SCLC treatment by disrupting PKA signaling.
Related Concept Videos
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
The Sympathetic Nervous System
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Sympathetic Division of the ANS
Originating in the thoracic and lumbar spinal cord segments, the preganglionic fibers of the sympathetic division exit the spinal cord through the white ramus communicans. They then enter the...
Sympathetic Activation
Gross Anatomy of the Lungs

